FR2683723B1 - Nouveaux medicaments antiviraux actifs sur le virus vih. - Google Patents

Nouveaux medicaments antiviraux actifs sur le virus vih.

Info

Publication number
FR2683723B1
FR2683723B1 FR9113999A FR9113999A FR2683723B1 FR 2683723 B1 FR2683723 B1 FR 2683723B1 FR 9113999 A FR9113999 A FR 9113999A FR 9113999 A FR9113999 A FR 9113999A FR 2683723 B1 FR2683723 B1 FR 2683723B1
Authority
FR
France
Prior art keywords
hiv virus
antiviral drugs
new antiviral
drugs active
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9113999A
Other languages
English (en)
Other versions
FR2683723A1 (fr
Inventor
Michel Seman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratories Mayoly Spindler SAS
Original Assignee
Laboratories Mayoly Spindler SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9113999A priority Critical patent/FR2683723B1/fr
Application filed by Laboratories Mayoly Spindler SAS filed Critical Laboratories Mayoly Spindler SAS
Priority to PCT/FR1992/001056 priority patent/WO1993009791A2/fr
Priority to MX9206563A priority patent/MX9206563A/es
Priority to AU31628/93A priority patent/AU669143B2/en
Priority to EP19920403057 priority patent/EP0542630A3/fr
Priority to CA002099490A priority patent/CA2099490A1/fr
Priority to JP5506429A priority patent/JPH06504295A/ja
Priority to US08/087,709 priority patent/US5514662A/en
Priority to TW081109073A priority patent/TW225991B/zh
Priority to KR1019930702119A priority patent/KR930702994A/ko
Publication of FR2683723A1 publication Critical patent/FR2683723A1/fr
Application granted granted Critical
Publication of FR2683723B1 publication Critical patent/FR2683723B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR9113999A 1991-11-14 1991-11-14 Nouveaux medicaments antiviraux actifs sur le virus vih. Expired - Fee Related FR2683723B1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR9113999A FR2683723B1 (fr) 1991-11-14 1991-11-14 Nouveaux medicaments antiviraux actifs sur le virus vih.
TW081109073A TW225991B (fr) 1991-11-14 1992-11-13
AU31628/93A AU669143B2 (en) 1991-11-14 1992-11-13 Use of amphotericin B derivatives as protease inhibitors
EP19920403057 EP0542630A3 (en) 1991-11-14 1992-11-13 Use of derivatives of amphotericin b as protease inhibitors
CA002099490A CA2099490A1 (fr) 1991-11-14 1992-11-13 Utilisation de derives d'amphotericine b comme inhibiteurs de proteases
JP5506429A JPH06504295A (ja) 1991-11-14 1992-11-13 アンフォテリシンｂ誘導体のプロテアーゼ阻害剤としての使用
PCT/FR1992/001056 WO1993009791A2 (fr) 1991-11-14 1992-11-13 Utilisation de derives d'amphotericine b, comme inhibiteurs de proteases
MX9206563A MX9206563A (es) 1991-11-14 1992-11-13 Utilizacion de derivados de anfotericina b como inhibidores de proteasas.
KR1019930702119A KR930702994A (ko) 1991-11-14 1992-11-13 암포테리신 b 유도체의 프로테아제 저해제로서의 용도
US08/087,709 US5514662A (en) 1991-11-14 1992-11-13 Use of amphotericin B derivatives as protease inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9113999A FR2683723B1 (fr) 1991-11-14 1991-11-14 Nouveaux medicaments antiviraux actifs sur le virus vih.

Publications (2)

Publication Number Publication Date
FR2683723A1 FR2683723A1 (fr) 1993-05-21
FR2683723B1 true FR2683723B1 (fr) 1995-05-19

Family

ID=9418894

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9113999A Expired - Fee Related FR2683723B1 (fr) 1991-11-14 1991-11-14 Nouveaux medicaments antiviraux actifs sur le virus vih.

Country Status (10)

Country Link
US (1) US5514662A (fr)
EP (1) EP0542630A3 (fr)
JP (1) JPH06504295A (fr)
KR (1) KR930702994A (fr)
AU (1) AU669143B2 (fr)
CA (1) CA2099490A1 (fr)
FR (1) FR2683723B1 (fr)
MX (1) MX9206563A (fr)
TW (1) TW225991B (fr)
WO (1) WO1993009791A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA93002392A (es) 1992-03-11 2005-02-04 Narhex Ltd Derivados amino de hidrocarburos-oxo e hidroxi-substituidos.
US5888992A (en) 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
US5679688A (en) 1992-03-11 1997-10-21 Narhex Limited Quinaldoyl-amine derivatives of oxo-and hydroxy-substituted hydrocarbons
US6071895A (en) 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
US6869925B1 (en) 1992-09-09 2005-03-22 Amgen Inc. Inhibition of retrovirus infection
IL110898A0 (en) * 1993-09-10 1994-11-28 Narhex Australia Pty Ltd Polar-substituted hydrocarbons
US6017880A (en) * 1994-03-09 2000-01-25 Amgen Inc. Inhibition of retrovirus infection
GB2290708A (en) * 1994-06-28 1996-01-10 Georgi Stankov Pharmaceutical uses of polyene macrolides
GB2290707A (en) * 1994-06-28 1996-01-10 Georgi Stankov Pharmaceutical uses of Amphotericin B
US6413537B1 (en) 2000-03-10 2002-07-02 Wisconsin Alumni Research Foundation Nystatin formulation having reduced toxicity
JP2003327536A (ja) 2002-03-07 2003-11-19 Kitasato Inst:The ヒト免疫不全症候群ウイルスの感染、増殖抑制剤
US20060194814A1 (en) * 2003-06-02 2006-08-31 Vassilios Papadopoulos Benzamide compounds
WO2005112922A2 (fr) * 2004-04-22 2005-12-01 Samaritan Pharmaceuticals Composes benzamide
WO2015190587A1 (fr) 2014-06-12 2015-12-17 塩野義製薬株式会社 Dérivé de macrolide de polyène

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0350164A3 (fr) * 1988-06-13 1991-07-24 Beecham Group Plc Dérivés-amphotéricine
GB8829592D0 (en) * 1988-12-19 1989-02-08 Beecham Group Plc Novel compounds
GB8829593D0 (en) * 1988-12-19 1989-02-08 Beecham Group Plc Novel compounds
US5175172A (en) * 1988-12-19 1992-12-29 Francois Dietlin Method of alleviating AIDS symptoms and compositions therefor
FR2654339B1 (fr) * 1989-11-14 1994-10-28 Mayoly Spindler Laboratoires Nouveaux derives solubles et non toxiques des macrolides polyeniques basiques, leur preparation et leurs applications.
EP0431874A1 (fr) * 1989-12-08 1991-06-12 Beecham Group p.l.c. Nouveaux composés
EP0431870A1 (fr) * 1989-12-08 1991-06-12 Beecham Group p.l.c. DÀ©rivés d'amphotéricine B
US5185366A (en) * 1990-07-31 1993-02-09 Ohio State University Research Foundation Method for treatment and prevention of diseases caused by enveloped viruses, including herpes simplex virus types 1 and 2 diseases, using 3,4-dihydroxy-2H-benzopyran-2H-one
US5120718A (en) * 1991-06-13 1992-06-09 Abbott Laboratories Candida acid protease inhibiting compounds
EP0599977A1 (fr) * 1991-08-14 1994-06-08 SEQUUS PHARMACEUTICALS, INC. (a Delaware Corporation) Procede de traitement contre le vih avec de l'amphotericine b a faible toxicite

Also Published As

Publication number Publication date
FR2683723A1 (fr) 1993-05-21
MX9206563A (es) 1993-11-01
KR930702994A (ko) 1993-11-29
CA2099490A1 (fr) 1993-05-15
JPH06504295A (ja) 1994-05-19
AU3162893A (en) 1993-06-15
WO1993009791A2 (fr) 1993-05-27
AU669143B2 (en) 1996-05-30
TW225991B (fr) 1994-07-01
US5514662A (en) 1996-05-07
WO1993009791A3 (fr) 1993-06-24
EP0542630A2 (fr) 1993-05-19
EP0542630A3 (en) 1993-08-04

Similar Documents

Publication Publication Date Title
FI923443A0 (fi) Foereningar och foerfarande foer inhibering av hiv och liknande virus.
DE68911473D1 (de) Arzneimittelformulierungen.
FI911574A0 (fi) Nya hiv-proteiner och -peptider anvaendbara vid diagnos, profylax och terapi av aids.
FI921060A0 (fi) Farmaceutiska aerosolformuleringar.
FI922958A0 (fi) Farmaceutisk sammansaettning.
FI893340A0 (fi) Foerfarande foer att erhaolla farmaceutiska sammansaettningar foer att hindra smittbara koenssjukdomar.
FI922252A0 (fi) Farmaceutisk sammansaettning.
FI922316A0 (fi) Farmaceutisk sammansaettning.
FI935073A (fi) Nya tiopyranopyrrolderivat, framstaellning av dem och dessa innehaollande farmaceutiska sammansaettningar
FI915826A (fi) Farmaceutiska aemnen.
IT9048521A0 (it) Dispositivo di somministrazione.
FI923581A0 (fi) Farmaceutisk kombinationsformation.
FI900313A0 (fi) Nya benzopyranderivat, deras framstaellning och dessa innehaollande farmaceutiska preparat.
NL195028B (nl) Cyclosporinebevattend farmaceutisch preparaat.
FI905510A0 (fi) Nya bensoxazinderivat och dessa innehaollande farmaceutiska blandningar.
FR2683723B1 (fr) Nouveaux medicaments antiviraux actifs sur le virus vih.
FI915152A0 (fi) Synergism hos inhibitorer foer reverserade transkriptaser i hiv.
FI890874A0 (fi) Expression av hiv-bindningsproteiner.
FI894629A (fi) Nya 3,4-diaminokinolin- och -pyridinfoereningar.
FI872897A0 (fi) Nya 4-pyridonderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat.
FR2675802B1 (fr) Antiserotonines, leur preparation et les medicaments les contenant.
FI875086A (fi) Nya benzotiadiazinfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
DK0587047T3 (da) Farmaceutisk præparat på gestagenbasis
NO892764L (no) Medikamentell administreringsform for droevtyggere.
FI890285A (fi) Nya aminosyraglycerider, foerfaranden foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning.

Legal Events

Date Code Title Description
AM Act modifying the rights related to an application or a patent
ST Notification of lapse